Results 151 to 160 of about 26,436 (212)

Association of week-2 Contrast-Enhanced Ultrasound Perfusion Changes with Response to Lenvatinib Plus PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study. [PDF]

J Hepatocell Carcinoma
Su H, Gao Y, Zhang S, Wen PH.
europepmc   +1 more source

Neoadjuvant lenvatinib and pembrolizumab for metastatic clear cell renal cell carcinoma: A potential opportunity for complete pathologic and radiographic response. [PDF]

Urol Case Rep
Walker EK, Leong JY, Aron M, Aron M.
europepmc   +1 more source

Predictive Value of On-Treatment Alpha-Fetoprotein Change for Lenvatinib Response in Patients with Hepatocellular Carcinoma: A Real-World Retrospective Study in Vietnam. [PDF]

Medicina (Kaunas)
Hoang NT, Le VQ, Tran T, Pham TQ, Nguyen TD, Hoang TC, Pham TP, Nguyen TH.   +7 more
europepmc   +1 more source

Efficacy of lenvatinib combined with sintilimab and transcatheter arterial chemoembolization in conversion therapy for unresectable hepatocellular carcinoma. [PDF]

Pak J Med Sci
Long J, Zheng J, Chen S, Ou P, Lu X.
europepmc   +1 more source

Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. [PDF]

World J Oncol
Roy P, Banik D, Chowdhury F, Bakar Siddique MA.   +3 more
europepmc   +1 more source

p53-R280S mutation confers lenvatinib resistance in hepatocellular carcinoma via Bcl-2-mediated anti-apoptotic signaling. [PDF]

Mol Cell Biochem
Cheng N, Liu K, Qi X, Cai L, Zhou Y, Wang F, Zhao B, Wang Y.   +7 more
europepmc   +1 more source

Case Report: Neuropsychiatric and cognitive phenomena in a highly complex patient affected by psychiatric and oncological diseases. [PDF]

Front Psychiatry
Borghesani A, Trottner K, Wedmann FM, Bertoldi B, Tondulli L, Farsad M, Spimpolo A, Boschello F, Conca A.   +8 more
europepmc   +1 more source

Combined effects of Lenvatinib and zinc oxide nanoparticles by promoting apoptosis and anti-proliferative activity in mice bearing Ehrlich solid tumors. [PDF]

Discov Nano
Zahran F, El-Metwaly S, A Shaaban A, Nabil A.   +3 more
europepmc   +1 more source

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations. [PDF]

Mediastinum
Kim HS, Padda SK.
europepmc   +1 more source